IP Verse

Effective Generation Of Tumor Targeted T Cells Derived From Pluripotent Stem Cells - EP2981607

PATENT ANALYSIS

Patent Details

Grant Date
Aug 19, 2020
Company
MEMORIAL SLOAN KETTERING CANCER CENTER
Oppositions

STRAWMAN LIMITED

VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

More patents of Memorial Sloan Kettering Cancer Center

EP2981607

EP2773748

Want to monitor this patent?

Feel free to send us a message here and we will get back to you